title: The rs11705701 G>A polymorphism of IGF2BP2 is associated with IGF2BP2 mRNA and protein levels in the visceral adipose tissue - a link to type 2 diabetes susceptibility.
abstract: BACKGROUND
  Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) regulates translation of IGF2, a growth factor that plays a key role in controlling fetal growth and organogenesis including adipogenesis and pancreatic development. In Caucasians, the rs4402960 G>T polymorphism of IGF2BP2 has been shown to predispose to type 2 diabetes (T2D) in multiple populations. In this study, we tested whether rs4402960 G>T and rs11705701 G>A contribute to the development of T2D in a Russian population.
  
  
  METHODS
  Both markers were genotyped in Russian diabetic (n = 1,470) and non-diabetic patients (n = 1,447) using a Taqman allele discrimination assay. The odds ratio (OR) for the risk of developing T2D was calculated using logistic regression assuming an additive genetic model adjusted for age, sex, HbA1c, hypertension, obesity, and body mass index (BMI). Multivariate linear regression analyses were used to test genotype-phenotype correlations, and adjusted for age, sex, hypertension, obesity, and BMI. Expression of IGF2BP2 in the visceral adipose tissue was quantified using real-time PCR. The content of IGF2BP2 protein and both its isoforms (p58 and p66) in the adipose tissue was measured using Western blot analysis.
  
  
  RESULTS
  There was no significant association between rs4402960 and T2D. Whereas, allele A of rs11705701 was associated with higher T2D risk (OR = 1.19, p < 0.001). Diabetic and non-diabetic carriers of genotype TT (rs4402960) had significantly increased HOMA-IR (p = 0.033 and p = 0.031, respectively). Non-diabetic patients homozygous for AA (rs11705701) had higher HOMA-IR (p = 0.04), lower HOMA-β (p = 0.012), and reduced 2-h insulin levels (p = 0.016). Non-obese individuals (diabetic and non-diabetic) homozygous for either AA (rs11705701) or TT (rs4402960) had higher levels of IGF2BP2 mRNA in the adipose tissue than other IGF2BP2 variants. Also, allele A of rs11705701 was associated with reduced amounts of the short isoform (p58) and increased levels of the long isoform (p66) of the IGF2BP2 protein in adipose tissue of non-obese diabetic and non-diabetic subjects.
  
  
  CONCLUSIONS
  IGF2BP2 genetic variants contribute to insulin resistance in Russian T2D patients. The short protein isoform p58 of IGF2BP2 is likely to play an anti-diabetogenic role in non-obese individuals.
authors: Pirogov Russian State Medical University, 117997 Moscow, Russia. dimitry.chistiakov@lycos.com
authors: Dimitry A
authors: DA
authors: Chistiakov
authors: Alexey G
authors: AG
authors: Nikitin
authors: Svetlana A
authors: SA
authors: Smetanina
authors: Larisa N
authors: LN
authors: Bel'chikova
authors: Lyudmila A
authors: LA
authors: Suplotova
authors: Marina V
authors: MV
authors: Shestakova
authors: Valery V
authors: VV
authors: Nosikov
mesh_terms: D001706:Biopsy; D015331:Cohort Studies; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics* / Q000378:metabolism*; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D050152:Intra-Abdominal Fat / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide; D012313:RNA / Q000737:chemistry / Q000235:genetics; D016601:RNA-Binding Proteins / Q000235:genetics* / Q000378:metabolism*; D060888:Real-Time Polymerase Chain Reaction; D012044:Regression Analysis; D012426:Russia
chemical_list: C498779:IGF2BP2 protein, human; D016601:RNA-Binding Proteins; D012313:RNA
references: PLoS One. 2010 Jul 13;5(7):e11499
references: 20644627
references: Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W696-700
references: 15980566
references: Diabetes Care. 2011 Jan;34 Suppl 1:S62-9
references: 21193628
references: J Mol Endocrinol. 2009 Nov;43(5):187-95
references: 19429674
references: Science. 2007 Jun 1;316(5829):1341-5
references: 17463248
references: J Cell Sci. 2002 May 15;115(Pt 10):2087-97
references: 11973350
references: Domest Anim Endocrinol. 2004 Oct;27(3):241-55
references: 15451072
references: Diabetologia. 2008 Sep;51(9):1659-63
references: 18618095
references: Nature. 2007 Jun 7;447(7145):661-78
references: 17554300
references: FEBS J. 2005 May;272(9):2118-31
references: 15853797
references: Diabetologia. 1985 Jul;28(7):412-9
references: 3899825
references: Genes Dev. 2011 Jun 1;25(11):1159-72
references: 21576258
references: Diabetologia. 2008 Jun;51(6):971-7
references: 18437351
references: Diabetes. 2009 Jun;58(6):1428-33
references: 19228808
references: Diabetes Care. 2009 Jul;32(7):1327-34
references: 19502545
references: Mol Cell Proteomics. 2007 May;6(5):798-811
references: 17289661
references: Bioinformatics. 2004 May 22;20(8):1325-6
references: 14871868
references: Gastroenterology. 2003 Jun;124(7):1901-14
references: 12806623
references: Mol Cell Biol. 1999 Feb;19(2):1262-70
references: 9891060
references: Diabet Med. 1999 May;16(5):442-3
references: 10342346
references: Diabetes. 2008 Jul;57(7):1992-6
references: 18430866
references: Mol Cell. 2002 Jun;9(6):1161-7
references: 12086614
references: Diabetes. 2009 Sep;58(9):2129-36
references: 19502414
references: Obesity (Silver Spring). 2009 Apr;17(4):729-36
references: 19148120
references: Diabetes. 2009 Jun;58(6):1440-4
references: 19258437
references: Dev Biol. 2006 Apr 15;292(2):442-56
references: 16680827
references: N Engl J Med. 2008 Nov 20;359(21):2220-32
references: 19020324
references: Diabetes. 2010 Aug;59(8):2068-74
references: 20424228
references: Biochem J. 2003 Dec 1;376(Pt 2):383-91
references: 12921532
references: Diabetes. 2008 Oct;57(10):2834-42
references: 18633108
references: Diabetes. 2008 Mar;57(3):791-5
references: 18162508
references: Diabetes. 2008 Sep;57(9):2503-10
references: 18544707
references: J Clin Endocrinol Metab. 2008 Aug;93(8):3136-41
references: 18477659
references: DNA Cell Biol. 2012 May;31(5):713-20
references: 22032244
references: Science. 2007 Jun 1;316(5829):1331-6
references: 17463246
references: BMC Med Genomics. 2009 Dec 31;2:72
references: 20043853
references: Dongwuxue Yanjiu. 2011 Feb;32(1):50-5
references: 21341384
references: Diabetes. 2001 Feb;50 Suppl 1:S84-8
references: 11272209
references: Diabetes. 2007 Dec;56(12):3105-11
references: 17827400
references: Diabetes. 2009 Jun;58(6):1255-6
references: 19461116
references: Growth Horm IGF Res. 2010 Aug;20(4):310-8
references: 20627640
references: Methods. 2001 Dec;25(4):402-8
references: 11846609
references: Diabetes. 2008 Aug;57(8):2226-33
references: 18469204
references: Diabetologia. 2010 Nov;53(11):2334-9
references: 20703447
references: Nature. 2007 Feb 22;445(7130):881-5
references: 17293876
references: PLoS One. 2009 Oct 28;4(10):e7643
references: 19862325
references: J Nutrigenet Nutrigenomics. 2009;2(4-5):225-34
references: 20215779
references: PLoS One. 2012;7(3):e33140
references: 22427968
references: Arch Med Res. 2011 Jul;42(5):361-7
references: 21839790
references: Genome Res. 2001 Jul;11(7):1262-8
references: 11435409
references: Nat Genet. 2007 Jun;39(6):770-5
references: 17460697
references: Diabetologia. 2007 Jul;50(7):1463-71
references: 17476475